Skip to main content
Top
Published in: Supportive Care in Cancer 7/2014

01-07-2014 | Original Article

HSV-1 as well as HSV-2 is frequent in oral mucosal lesions of children on chemotherapy

Authors: Ritu Aggarwal, Deepak Bansal, Jasmine Naru, Manila Salaria, Anita Rana, Ranjana W. Minz, Amita Trehan, R. K. Marwaha

Published in: Supportive Care in Cancer | Issue 7/2014

Login to get access

Abstract

Purpose

Prevalence data of herpes simplex virus (HSV) in oral mucositis in children on treatment for cancer is limited. Quantitative polymerase chain reaction (PCR) has been seldom utilized for detection of HSV-1/2 in oral mucosa.

Methods

Children on treatment for cancer with oral mucositis were enrolled as cases and healthy children as controls. An oral swab from the lesion in cases and mucosal scraping in controls were obtained. Both qualitative and real-time quantitative PCR for HSV-1/2 were performed. Serum ELISA-IgG/IgM for HSV-1/2 antibodies (NovaLisa™-Dietzenbach-Germany) were measured.

Results

Thirty-two cases (Age, 6.3 ± 3.4 years) and 30 controls were enrolled. Majority (69 %) of cases had ALL. All patients had febrile neutropenia, except two. ELISA-IgM-HSV-1/2 was not positive in any case or control. ELISA-IgG-HSV-1/2 was positive in 11 (34 %) cases and nine (30 %) controls (p = 1.0). Qualitative PCR for HSV-1 detected the virus in eight (25 %) cases and nil controls (p = 0.009). HSV-2 was not detected in any case/control by qualitative PCR. Quantitative PCR detected HSV-1 in 21 (66 %) and HSV-2 in 22 (69 %) cases. In controls, quantitative PCR detected HSV-1 in three (10 %) and HSV-2 in none. In patients, the mean viral load of HSV-1 (5,500 ± 15,987 × 104 copies/nanogram DNA) was more than HSV-2 (4.03 ± 8.5 × 104) (p = 0.11). There was no correlation of HSV-1/2 with grading of mucositis.

Conclusions

Both HSV-1/2 are commonly shed from oral mucosal lesions in children receiving chemotherapy. In a novel finding, real-time PCR detected copies of HSV-2 in 69 % cases, all missed by conventional PCR. Implication for morbidity, if any, or treatment needs to be determined.
Literature
1.
go back to reference Fulton J, Middleton G, McPhail J (2002) Management of oral complications. Semin Oncol Nurs 18:28–35PubMedCrossRef Fulton J, Middleton G, McPhail J (2002) Management of oral complications. Semin Oncol Nurs 18:28–35PubMedCrossRef
2.
go back to reference Dodd M, Miaskowski C, Dibble S et al (2000) Factors influencing oral mucositis in patients receiving chemotherapy. Cancer Pract 8:291–297PubMedCrossRef Dodd M, Miaskowski C, Dibble S et al (2000) Factors influencing oral mucositis in patients receiving chemotherapy. Cancer Pract 8:291–297PubMedCrossRef
3.
go back to reference Elad S, Zadik Y, Hewson I et al (2010) Viral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer 18:993–1006PubMedCrossRef Elad S, Zadik Y, Hewson I et al (2010) Viral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer 18:993–1006PubMedCrossRef
4.
go back to reference Glenny AM, Gibson F, Auld E et al (2010) Children’s Cancer and Leukaemia Group (CCLG)/Paediatric Oncology Nurses Forum’s (CCLG-PONF) Mouth Care Group. The development of evidence-based guidelines on mouth care for children, teenagers and young adults treated for cancer. Eur J Cancer 46:1399–1412PubMedCrossRef Glenny AM, Gibson F, Auld E et al (2010) Children’s Cancer and Leukaemia Group (CCLG)/Paediatric Oncology Nurses Forum’s (CCLG-PONF) Mouth Care Group. The development of evidence-based guidelines on mouth care for children, teenagers and young adults treated for cancer. Eur J Cancer 46:1399–1412PubMedCrossRef
5.
go back to reference Djuric M, Jankovic L, Jovanovic T et al (2009) Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection. J Oral Pathol Med 38:167–173PubMedCrossRef Djuric M, Jankovic L, Jovanovic T et al (2009) Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection. J Oral Pathol Med 38:167–173PubMedCrossRef
6.
go back to reference Stanberry LR (2011) Herpes simplex virus. In: Kliegman RM, Stanton BF, StGeme JW, Schor NF, Behrman RE (eds) Nelson textbook of pediatrics, 19th edn. Saunders, Philadelphia, pp 1097–1104CrossRef Stanberry LR (2011) Herpes simplex virus. In: Kliegman RM, Stanton BF, StGeme JW, Schor NF, Behrman RE (eds) Nelson textbook of pediatrics, 19th edn. Saunders, Philadelphia, pp 1097–1104CrossRef
7.
go back to reference Usatine RP, Tinitigan R (2010) Nongenital herpes simplex virus. Am Fam Physician 82:1075–1082PubMed Usatine RP, Tinitigan R (2010) Nongenital herpes simplex virus. Am Fam Physician 82:1075–1082PubMed
8.
go back to reference Sandoval RL, Koga DH, Buloto LS, Suzuki R, Dib LL (2003) Management of chemo- and radiotherapy induced oral mucositis with low-energy laser: initial results of A.C. Camargo Hospital. J Appl Oral Sci 11:337–341PubMedCrossRef Sandoval RL, Koga DH, Buloto LS, Suzuki R, Dib LL (2003) Management of chemo- and radiotherapy induced oral mucositis with low-energy laser: initial results of A.C. Camargo Hospital. J Appl Oral Sci 11:337–341PubMedCrossRef
9.
go back to reference Figliolia SL, Oliveira DT, Pereira MC et al (2008) Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. Oral Dis 14:761–766PubMedCrossRef Figliolia SL, Oliveira DT, Pereira MC et al (2008) Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. Oral Dis 14:761–766PubMedCrossRef
10.
go back to reference Childers NK, Stinnett EA, Wheeler P et al (1993) Oral complications in children with cancer. Oral Surg Oral Med Oral Pathol 75:41–47PubMedCrossRef Childers NK, Stinnett EA, Wheeler P et al (1993) Oral complications in children with cancer. Oral Surg Oral Med Oral Pathol 75:41–47PubMedCrossRef
11.
go back to reference Dreizen S, McCredie KB, Bodey GP, Keating MJ (1986) Quantitative analysis of the oral complications of antileukemia chemotherapy. Oral Surg Oral Med Oral Pathol 62:650–653PubMedCrossRef Dreizen S, McCredie KB, Bodey GP, Keating MJ (1986) Quantitative analysis of the oral complications of antileukemia chemotherapy. Oral Surg Oral Med Oral Pathol 62:650–653PubMedCrossRef
12.
go back to reference Greenberg MS (1996) Herpesvirus infections. Dent Clin North Am 40:359–368PubMed Greenberg MS (1996) Herpesvirus infections. Dent Clin North Am 40:359–368PubMed
13.
go back to reference Heimdahl A (1999) Prevention and management of oral infections in cancer patients. Support Care Cancer 7:224–228PubMedCrossRef Heimdahl A (1999) Prevention and management of oral infections in cancer patients. Support Care Cancer 7:224–228PubMedCrossRef
14.
go back to reference Baglin TP, Gray JJ, Marcus RE, Wreghitt TG (1989) Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy. J Clin Pathol 42:1255–1258PubMedCentralPubMedCrossRef Baglin TP, Gray JJ, Marcus RE, Wreghitt TG (1989) Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy. J Clin Pathol 42:1255–1258PubMedCentralPubMedCrossRef
15.
go back to reference Lönnqvist B, Palmblad J, Ljungman P et al (1993) Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden. Support Care Cancer 1:139–144PubMedCrossRef Lönnqvist B, Palmblad J, Ljungman P et al (1993) Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden. Support Care Cancer 1:139–144PubMedCrossRef
16.
go back to reference Hann IM, Prentice HG, Blacklock HA et al (1983) Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) 287:384–388CrossRef Hann IM, Prentice HG, Blacklock HA et al (1983) Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) 287:384–388CrossRef
17.
go back to reference Rubenstein EB, Peterson DE, Schubert M et al (2004) Mucositis study section of the multinational association for supportive care in cancer; international society for oral oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026–2046PubMedCrossRef Rubenstein EB, Peterson DE, Schubert M et al (2004) Mucositis study section of the multinational association for supportive care in cancer; international society for oral oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026–2046PubMedCrossRef
18.
go back to reference de Mendonça RM, de Araújo M, Levy CE et al (2012) Prospective evaluation of HSV, Candida spp., and oral bacteria on the severity of oral mucositis in pediatric acute lymphoblastic leukemia. Support Care Cancer 20:1101–1107PubMedCrossRef de Mendonça RM, de Araújo M, Levy CE et al (2012) Prospective evaluation of HSV, Candida spp., and oral bacteria on the severity of oral mucositis in pediatric acute lymphoblastic leukemia. Support Care Cancer 20:1101–1107PubMedCrossRef
19.
go back to reference Ramphal R, Grant RM, Dzolganovski B et al (2007) Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study. Pediatr Infect Dis J 26:700–704PubMedCrossRef Ramphal R, Grant RM, Dzolganovski B et al (2007) Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study. Pediatr Infect Dis J 26:700–704PubMedCrossRef
20.
go back to reference Sepúlveda E, Brethauer U, Rojas J, Fernández E, Le Fort P (2005) Oral ulcers in children under chemotherapy: clinical characteristics and their relation with herpes simplex virus type 1 and Candida albicans. Med Oral Patol Oral Circ Bucal 10(Suppl 1):E1–E8 Sepúlveda E, Brethauer U, Rojas J, Fernández E, Le Fort P (2005) Oral ulcers in children under chemotherapy: clinical characteristics and their relation with herpes simplex virus type 1 and Candida albicans. Med Oral Patol Oral Circ Bucal 10(Suppl 1):E1–E8
21.
go back to reference Anirudhan D, Bakhshi S, Xess I, Broor S, Arya LS (2008) Etiology and outcome of oral mucosal lesions in children on chemotherapy for acute lymphoblastic leukemia. Indian Pediatr 45:47–51PubMed Anirudhan D, Bakhshi S, Xess I, Broor S, Arya LS (2008) Etiology and outcome of oral mucosal lesions in children on chemotherapy for acute lymphoblastic leukemia. Indian Pediatr 45:47–51PubMed
22.
go back to reference Carrega G, Castagnola E, Canessa A et al (1994) Herpes simplex virus and oral mucositis in children with cancer. Support Care Cancer 2:266–269PubMedCrossRef Carrega G, Castagnola E, Canessa A et al (1994) Herpes simplex virus and oral mucositis in children with cancer. Support Care Cancer 2:266–269PubMedCrossRef
23.
go back to reference Chayavichitsilp P, Buckwalter JV, Krakowski AC, Friedlander SF (2009) Herpes simplex. Pediatr Rev 30:119–129PubMedCrossRef Chayavichitsilp P, Buckwalter JV, Krakowski AC, Friedlander SF (2009) Herpes simplex. Pediatr Rev 30:119–129PubMedCrossRef
24.
go back to reference Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L (1987) Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 316:1444–1449PubMedCrossRef Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L (1987) Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 316:1444–1449PubMedCrossRef
25.
go back to reference Wald A, Huang ML, Carrell D, Selke S, Corey L (2003) Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 188:1345–1351PubMedCrossRef Wald A, Huang ML, Carrell D, Selke S, Corey L (2003) Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 188:1345–1351PubMedCrossRef
26.
go back to reference Augenbraun M, Corey L, Reichelderfer P et al (2001) Women’s Health Studies 002 Study Group. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women. Clin Infect Dis 33:885–890PubMedCrossRef Augenbraun M, Corey L, Reichelderfer P et al (2001) Women’s Health Studies 002 Study Group. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women. Clin Infect Dis 33:885–890PubMedCrossRef
28.
go back to reference Zuckerman RA (2009) The clinical spectrum of herpes simplex viremia. Clin Infect Dis 49:1302–1304PubMedCrossRef Zuckerman RA (2009) The clinical spectrum of herpes simplex viremia. Clin Infect Dis 49:1302–1304PubMedCrossRef
29.
go back to reference Tyler KL (2004) Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret’s. Herpes 11(Suppl 2):57A–64APubMed Tyler KL (2004) Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret’s. Herpes 11(Suppl 2):57A–64APubMed
30.
go back to reference Mark KE, Wald A, Magaret AS et al (2008) Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 198:1141–1149PubMedCentralPubMedCrossRef Mark KE, Wald A, Magaret AS et al (2008) Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 198:1141–1149PubMedCentralPubMedCrossRef
32.
go back to reference Glenny AM, Fernandez Mauleffinch LM, Pavitt S, Walsh T (2009) Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer. Cochrane Database Syst Rev 1, CD006706PubMed Glenny AM, Fernandez Mauleffinch LM, Pavitt S, Walsh T (2009) Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer. Cochrane Database Syst Rev 1, CD006706PubMed
Metadata
Title
HSV-1 as well as HSV-2 is frequent in oral mucosal lesions of children on chemotherapy
Authors
Ritu Aggarwal
Deepak Bansal
Jasmine Naru
Manila Salaria
Anita Rana
Ranjana W. Minz
Amita Trehan
R. K. Marwaha
Publication date
01-07-2014
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 7/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2152-0

Other articles of this Issue 7/2014

Supportive Care in Cancer 7/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine